1. Home
  2. ENSC vs YMAT Comparison

ENSC vs YMAT Comparison

Compare ENSC & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

N/A

Current Price

$0.39

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Logo J-Star Holding Co. Ltd. Ordinary Shares

YMAT

J-Star Holding Co. Ltd. Ordinary Shares

N/A

Current Price

$1.42

Market Cap

8.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
ENSC
YMAT
Founded
2003
1970
Country
United States
Taiwan
Employees
10
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
8.1M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
ENSC
YMAT
Price
$0.39
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
★ $5.13
N/A
AVG Volume (30 Days)
535.6K
★ 5.7M
Earning Date
11-13-2026
10-23-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 65.24
N/A
EPS
N/A
★ N/A
Revenue
★ $5,066,650.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$10.92
Revenue Growth
N/A
★ N/A
52 Week Low
$0.23
$0.24
52 Week High
$2.17
$4.49

Technical Indicators

Market Signals
Indicator
ENSC
YMAT
Relative Strength Index (RSI) 36.37 43.54
Support Level $0.39 $1.14
Resistance Level $0.44 $2.27
Average True Range (ATR) 0.05 0.47
MACD -0.01 -0.02
Stochastic Oscillator 2.44 7.02

Price Performance

Historical Comparison
ENSC
YMAT

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About YMAT J-Star Holding Co. Ltd. Ordinary Shares

J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.

Share on Social Networks: